Literature DB >> 7519715

Characterization of hemolytic and antifungal substance, cepalycin, from Pseudomonas cepacia.

M Abe1, T Nakazawa.   

Abstract

Hemolytic and antifungal substances, cepalycin I and cepalycin II, have been isolated from Pseudomonas cepacia JN106. A large amount of cepalycins were produced by growing the cells on 1% glycerin-nutrient agar medium covered with a cellophane membrane. The cell-washed supernatant was applied to an Amberlite XAD2 column, and cepalycins were eluted with 70% ethanol containing 1mM HCl. Cepalycins were separated by reverse phase HPLC in two fractions which were designated as cepalycin I and cepalycin II. The two cepalycins have indistinguishable UV absorption spectra but have different levels of hemolytic activity relative to the UV absorption. From the inhibition of hemolytic activity of cepalycin by sterols, both cepalycins were suggested to interact with cholesterol in erythrocyte membrane. Such an interaction may contribute to their hemolytic and antifungal activities.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7519715     DOI: 10.1111/j.1348-0421.1994.tb01737.x

Source DB:  PubMed          Journal:  Microbiol Immunol        ISSN: 0385-5600            Impact factor:   1.955


  10 in total

1.  Cloning and Analysis of Genes Controlling Antibacterial Activities of Burkholderia pyrrocinia Strain Lyc2.

Authors:  Xiaoqiang Wang; Dexin Chen; Jing Wang; Chao Feng; Wenjing Wang; Wei Zhang; Bin Li; Jiamin Yu; Bo Xia
Journal:  Curr Microbiol       Date:  2019-06-10       Impact factor: 2.188

Review 2.  Nonribosomal peptides and polyketides of Burkholderia: new compounds potentially implicated in biocontrol and pharmaceuticals.

Authors:  Qassim Esmaeel; Maude Pupin; Philippe Jacques; Valérie Leclère
Journal:  Environ Sci Pollut Res Int       Date:  2017-05-25       Impact factor: 4.223

3.  The dsbB gene product is required for protease production by Burkholderia cepacia.

Authors:  M Abe; T Nakazawa
Journal:  Infect Immun       Date:  1996-10       Impact factor: 3.441

4.  Burkholderia cepacia produces a hemolysin that is capable of inducing apoptosis and degranulation of mammalian phagocytes.

Authors:  M L Hutchison; I R Poxton; J R Govan
Journal:  Infect Immun       Date:  1998-05       Impact factor: 3.441

5.  Analysis of strains of Burkholderia (Pseudomonas) cepacia isolated in a nosocomial outbreak by biochemical and genomic typing.

Authors:  K Ouchi; M Abe; M Karita; T Oguri; J Igari; T Nakazawa
Journal:  J Clin Microbiol       Date:  1995-09       Impact factor: 5.948

6.  A Burkholderia cepacia complex non-ribosomal peptide-synthesized toxin is hemolytic and required for full virulence.

Authors:  Euan L S Thomson; Jonathan J Dennis
Journal:  Virulence       Date:  2012-05-01       Impact factor: 5.882

7.  Identification of quorum sensing-controlled genes in Burkholderia ambifaria.

Authors:  Annelise Chapalain; Ludovic Vial; Natacha Laprade; Valérie Dekimpe; Jonathan Perreault; Eric Déziel
Journal:  Microbiologyopen       Date:  2013-02-05       Impact factor: 3.139

8.  Burkholderia genome mining for nonribosomal peptide synthetases reveals a great potential for novel siderophores and lipopeptides synthesis.

Authors:  Qassim Esmaeel; Maude Pupin; Nam Phuong Kieu; Gabrielle Chataigné; Max Béchet; Jovana Deravel; François Krier; Monica Höfte; Philippe Jacques; Valérie Leclère
Journal:  Microbiologyopen       Date:  2016-04-05       Impact factor: 3.139

9.  Characterization of Burkholderia pseudomallei protein BPSL1375 validates the Putative hemolytic activity of the COG3176 N-Acyltransferase family.

Authors:  Laziana Ahmad; Teng Loong Hung; Nor Azurah Mat Akhir; Rahmah Mohamed; Sheila Nathan; Mohd Firdaus-Raih
Journal:  BMC Microbiol       Date:  2015-11-23       Impact factor: 3.605

Review 10.  Antimicrobial Compounds from Microorganisms.

Authors:  Cynthia Amaning Danquah; Prince Amankwah Baffour Minkah; Isaiah Osei Duah Junior; Kofi Bonsu Amankwah; Samuel Owusu Somuah
Journal:  Antibiotics (Basel)       Date:  2022-02-22
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.